|
Index of reports
> Cases resulting in hospitalization (274)
> Cases with Interstitial Lung Disease (19)
Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in hospitalization where reactions include interstitial lung disease.
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-06-20
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-06-18
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in female receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from Japan on 2007-06-15
Patient: female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Daonil; Basen; Actos; Prednisolone; Gaster D; Gaslon N (Irsogladine Maleate); Lipitor; Amlodin; Theolong; Hokunalin:tape (Ulobuterol); Dextromethorphan Hydrobromide
Adverse event in female receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from Japan on 2007-06-13
Patient: female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Daonil; Basen; Actos; Prednisolone; Gaster D; Gaslon N (Irsogladine Maleate); Lipitor; Amlodin; Theolong; Hokunalin:tape (Ulobuterol); Dextromethorphan Hydrobromide
Adverse event in female receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from Japan on 2007-06-11
Patient: female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Daonil; Basen; Actos; Prednisolone; Gaster D; Gaslon N (Irsogladine Maleate); Lipitor; Amlodin; Theolong; Hokunalin:tape (Ulobuterol); Dextromethorphan Hydrobromide
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-05-23
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-04-26
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-04-13
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Norvasc; Tenormin
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-28
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-03-27
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-01
Patient: male, weighing 68.5 kg (150.7 pounds)
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Urinorm; Lipovas; Tagamet; SLO-BID; Meptin; Uralyt; Aplace; TS-1
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-01
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-02-23
Patient: male, weighing 68.5 kg (150.7 pounds)
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Urinorm; Lipovas; Tagamet; SLO-BID; Meptin; Uralyt; Aplace; TS-1
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-02-20
Patient: male, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Urinorm; Lipovas; Tagamet; SLO-BID; Meptin; Uralyt; Aplace; TS-1
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-02-12
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Adverse event in male receiving Micardis (Telmisartan)
Reported by a pharmacist from Japan on 2007-02-08
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-01-30
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-02
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-02
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-02
|
